Plant-based products that do not contain meat can continue to be labeled “sausages” or “burgers,” European lawmakers said Friday, when they rejected a proposal back by the meat industry to ban the terms.

In votes on issues relating to agricultural products, the European Parliament said that so-called veggie burgers, soy steaks and vegan sausages can continue to be sold as such in restaurants and shops across the union.

Europe’s largest farmers' association, Copa-Cogeca, had supported a ban, arguing that labeling vegetarian substitutes with designations bringing meat to mind was misleading for consumers.

On the opposite side of the debate, a group of 13 organizations including Greenpeace and WWF urged lawmakers to reject the proposed amendments, arguing that a ban would have not only exposed the EU “to ridicule," but also damaged its environmental credibility.

They said promoting a shift toward more plant-based diet is in line with the EU Commission's ambition to tackle global warming. Losing the ability to use the terms steak or sausage might make those plant-based products more obscure for consumers.

After the vote, the European Consumer Organization, an umbrella group bringing together consumers' associations, praised the MEPs for their “common sense."

“Consumers are in no way confused by a soy steak or chickpea-based sausage, so long as it is clearly labeled as vegetarian or vegan," the group said in a statement. “Terms such as ‘burger’ or ‘steak’ on plant-based items simply make it much easier for consumers to know how to integrate these products within a meal."

Together with Greenpeace, the group regretted that lawmakers accepted further restrictions on the naming of alternative products containing no dairy. Terms like ‘almond milk’ and ‘soy yogurt’ are already banned in Europe after the bloc's top court ruled in 2017 that purely plant-based products can't be marketed using terms such as milk, butter or cheese, which are reserved for animal products.

Share:
More In Business
Markets Rebound on Potential Covid-19 Pill from Merck
Futures rebounded this morning in reaction to positive news from Merck that its covid-19 treatment pill is 50 percent effective at preventing hospitalizations and death. It comes after a rocky month on Wall Street, which saw all the major averages post their worst months in over a year. Chris Vecchio, Senior Analyst, at DailyFX joined Wake Up with Cheddar for more.
Weekly Jobless Claims Rise to 362,000, Missing Expectations of 335,000
U.S. weekly jobless claims rose to 362,000 for the week ending September 25th, higher than the 335,000 economists had expected. This figure is also slightly higher than the 351,000 reported a week earlier. Louis Cordone, Senior Vice President of Data Strategy at AST joined Wake Up with Cheddar to discuss.
Shipping, Supply Concerns Lead to Market Skepticism
David Wagner, Portfolio Manager and Equity Analyst at Aptus Capital Advisors, joined Cheddar News to break down what led to the worst day for the markets since May on Tuesday, and what investors are watching ahead of the market open.
Virgin Galactic Cleared to Resume Space Missions Following FAA Probe
The FAA has completed its investigation of Virgin Galactic’s Unity 22 test flight on July 12 after the aircraft flew out of protected airspace on its descent back to Earth. Virgin Galactic has been given the green light to resume flights but must request a larger share of protected airspace for future missions.
Load More